Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Randomized controlled trial of interferon A 5mU daily plus ribavirin 1000mg daily versus interferon A 3mU tiw plus ribavirin 1000mg daily in patients with HCV who have never received previous therapy

Afdhal NH, Brand M, Apstein A, Cooley J, Hoffman J, Mikolich D, Grace N, O'Connor C, Nunes DP. Randomized controlled trial of interferon A 5mU daily plus ribavirin 1000mg daily versus interferon A 3mU tiw plus ribavirin 1000mg daily in patients with HCV who have never received previous therapy. Hepatology. 2000; (32):363A.


Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.